The table below shows Edwards Lifesciences Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$43.80M
$280.40M
-$53.50M
$314.10M
$293.30M
$300.50M
Capital expenditure
$64.90M
$56.00M
$65.30M
$61.50M
$72.70M
$106.00M
Investing cash flow
-$92.80M
$85.30M
$63.10M
$500.00K
$229.50M
-$49.70M
Dividends paid
-
-
-
-
-
EW operating cash flow (10-K history)
Edwards Lifesciences Corp reported operating cash flow of $1.60B for fiscal year 2025. That is up 194.2% from $542.30M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $704.40M (FY 2016) to $1.60B. Figures come from the company's audited annual reports as filed with the SEC.
